Monoamine Oxidase Inhibitors: Augmentation of Pressor Effects of Peroral Tyramine
- 5 June 1964
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 144 (3623) , 1225-1226
- https://doi.org/10.1126/science.144.3623.1225
Abstract
Monoamine oxidase inhibitors markedly enhance the oral pressor potency of tyramine by preventing it from being destroyed by the monoamine oxidase normally present in liver and intestine. Since certain types of cheese contain high concentrations of tyramine, they should not be eaten by patients during treatment with a monoamine oxidase inhibitor.Keywords
This publication has 3 references indexed in Scilit:
- EVALUATION OF THE MONOAMINE OXIDASE INHIBITOR, PARGYLINE, AS AN ANTIHYPERTENSIVE AGENT: A. CLINICAL RESULTSAnnals of the New York Academy of Sciences, 1963
- The action of sympathomimetic amines in animals treated with reserpineThe Journal of Physiology, 1958
- The Influence of Temperature of Ripening on the Tyramine Content and Flavor of American Cheddar CheeseJournal of Dairy Science, 1949